Health Trials

Myelodysplastic/Myeloproliferative Neoplasms

4

Review clinical trials related to Myelodysplastic/Myeloproliferative Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Registry of Older Patients With Cancer

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.

Participants needed: 3,000
Trial details
Age: 65+Biological sex: AllType: ObservationalSponsor: UNC Lineberger Comprehensive Cancer CenterUpdated: Jun 29, 2026Locations: 7
Eligibility criteria

Patients must have an appointment at the North Carolina Cancer Hospital and agre... [+2]

Read more
Status: Recruiting

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Participants needed: 15,000
Trial details
Age: 18-120Biological sex: AllType: ObservationalSponsor: UNC Lineberger Comprehensive Cancer CenterUpdated: Oct 27, 2025Locations: 1
Eligibility criteria

Acute myeloid leukemia [+14]

Read more
Status: Recruiting

OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

A prospective, single center, single arm phase 2 cohort feasibility study of the OURA ring in adult MDS patients. Patients with MDS will wear the OURA ring and upload biometrics weekly. Quality of life measures will be clinically evaluated and correlated with biometrics. We hypothesize that it will be feasible for MDS patients to wear the OURA ring 70% of the time for 3 months.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Sunnybrook Health Sciences CentreUpdated: Jul 8, 2025Locations: 1
Eligibility criteria

Provision of signed and dated informed consent form [+5]

Performance status ECOG > 3. [+1]

Read more
Status: Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This phase I trial is studying FLT PET imaging in patients with cancer.

Trial details
Age: 18-120Biological sex: AllType: InterventionalSponsor: Barbara Ann Karmanos Cancer InstituteUpdated: Jul 8, 2025Locations: 1
Eligibility criteria

Histologically confirmed solid tumor or hematologic malignancy [+7]

Read more